Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.

[1]  T. Zuberbier,et al.  The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria , 2018, Allergy.

[2]  I. Braenne,et al.  Hereditary angioedema with a mutation in the plasminogen gene , 2018, Allergy.

[3]  M. Margaglione,et al.  Mutation of the angiopoietin‐1 gene (ANGPT1) associates with a new type of hereditary angioedema , 2017, The Journal of allergy and clinical immunology.

[4]  J. Bernstein,et al.  Current and future therapies for the treatment of histamine-induced angioedema , 2017, Expert opinion on pharmacotherapy.

[5]  M. Triggiani,et al.  International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency , 2016, Allergy.

[6]  H. Farkas,et al.  “Nuts and Bolts” of Laboratory Evaluation of Angioedema , 2016, Clinical Reviews in Allergy & Immunology.

[7]  K. Bork,et al.  Hereditary angioedema with normal C1‐INH with versus without specific F12 gene mutations , 2015, Allergy.

[8]  M. Cicardi,et al.  Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients , 2015, Journal of internal medicine.

[9]  I. Jáuregui,et al.  Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  A. Malbrán,et al.  Epidemiology of angioedema without wheals in an allergy and immunology center. , 2015, Medicina.

[11]  J. Bernstein,et al.  Diagnosis and Treatment of Bradykinin-Mediated Angioedema: Outcomes from an Angioedema Expert Consensus Meeting , 2014, International Archives of Allergy and Immunology.

[12]  J. Bernstein,et al.  Idiopathic nonhistaminergic angioedema successfully treated with ecallantide, icatibant, and C1 esterase inhibitor replacement. , 2014, The journal of allergy and clinical immunology. In practice.

[13]  A. Gompel,et al.  Tranexamic acid as maintenance treatment for non‐histaminergic angioedema: analysis of efficacy and safety in 37 patients , 2014, Clinical and experimental immunology.

[14]  M. Triggiani,et al.  Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group , 2014, Allergy.

[15]  K. Bork,et al.  Antihistamine-resistant angioedema in women with negative family history: estrogens and F12 gene mutations. , 2013, The American journal of medicine.

[16]  M. Cicardi,et al.  Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. , 2012, Allergy and asthma proceedings.

[17]  H. Farkas.  Management of upper airway edema caused by hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[18]  J. Oldenburg,et al.  Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema , 2008, Cytogenetic and Genome Research.

[19]  A. Kaplan.  Angioedema , 2008, The World Allergy Organization journal.

[20]  G. Kojda,et al.  Nonallergic angioedema: role of bradykinin , 2007, Allergy.

[21]  S. Cichon,et al.  Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. , 2006, American journal of human genetics.

[22]  M. Cicardi,et al.  Angioedema without urticaria: a large clinical survey , 2006, Canadian Medical Association Journal.

[23]  K. Bork,et al.  Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. , 2006, Biochemical and biophysical research communications.

[24]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[25]  M. Cicardi,et al.  Bradykinin and the pathophysiology of angioedema. , 2003, International immunopharmacology.

[26]  S. Choquet,et al.  Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. , 2000, The Journal of allergy and clinical immunology.

[27]  M. Cicardi,et al.  Idiopathic nonhistaminergic angioedema. , 1999, The American journal of medicine.